GET THE APP

Photophobia and Migraine Outcome during Treatment with Galca | 100768

神経学および神経生理学ジャーナル

ISSN - 2155-9562

概要

Photophobia and Migraine Outcome during Treatment with Galcanezumab

Catherine Lapp

The Calcitonin Gene-Related Peptide (CGRP), which affects both migraine pain and accompanying symptoms including photophobia, is crucial to the physiology of migraines. The current study sought to determine if monoclonal antibodies that target CGRP are effective in lowering ictal photophobia as well as headache and migraine frequency and disability.

免責事項: この要約は人工知能ツールを使用して翻訳されたものであり、まだレビューまたは検証されていません。